학술논문
Dostarlimab in the treatment of mismatch repair deficient recurrent or advanced endometrial cancer
Document Type
Review Article
Source
In Cancer Pathogenesis and Therapy July 2024 2(3):135-141
Subject
Language
ISSN
2949-7132